CLAUDIA SALCIDO: Open Payments
NPI 1821357955 · CATHEDRAL CITY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,501 in 80 payments from 20 companies in 2025. Trend: 2023 $1,336 · 2024 $1,639 · 2025 $1,501
Food & beverage: $1,501
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $205 |
| Galderma Laboratories, L.P. | 14 | $196 |
| Arcutis Biotherapeutics, Inc. | 18 | $190 |
| GENZYME CORPORATION | 3 | $155 |
| Incyte Corporation | 6 | $137 |
| LEO Pharma Inc. | 5 | $106 |
| Regeneron Healthcare Solutions, Inc. | 3 | $81 |
| Mallinckrodt Hospital Products Inc. | 3 | $79 |
| PFIZER INC. | 3 | $69 |
| Novartis Pharmaceuticals Corporation | 2 | $51 |
Products named: DUPIXENT, Zoryve, OPZELURA, NEMLUVIO, RINVOQ, SKYRIZI, ACTHAR, ADBRY.
Industry payments across CA — which companies pay providers there.
